
    
      This study is a randomized, blind, controlled phase III clinical trial. The purpose of this
      study is to evaluate the protective effect, safety and immunogenicity of a live attenuated
      varicella vaccine manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd. The control
      is diluent of lyophilized vaccine manufactured by Sinovac (Dalian) Vaccine Technology Co.,
      Ltd. All participants are healthy, and will be randomly assigned into experimental group or
      control group in the ratio 1:1.
    
  